2. Cell Cycle/DNA Damage Epigenetics
  3. PARP Histone Methyltransferase
  4. PARP/EZH2-IN-2

PARP/EZH2-IN-2 (compound 12e) 是一种双靶点 PARP1 和 EZH2 抑制剂，IC50 值分别为 6.89 和 27.34 nM。PARP/EZH2-IN-2 显示出抗癌活性，对正常细胞没有毒性。PARP/EZH2-IN-2 通过抑制 EZH2 去增加对 PARP1 的敏感性来间接实现合成致死，并通过调节过度自噬诱导细胞死亡。

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

PARP/EZH2-IN-2 Chemical Structure

PARP/EZH2-IN-2 Chemical Structure

1.  客户无需承担相应的运输费用。

2.  同一机构（单位）同一产品试用装仅限申领一次，同一机构（单位）一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户。

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

PARP/EZH2-IN-2 相关抗体

Top Publications Citing Use of Products

查看 PARP 亚型特异性产品:

查看所有亚型
PARP PARP1 PARP2 PARP3 PARP4 TNKS1/PARP5A TNKS2/PARP5B PARP7 PARP10 PARP14 PARP15 PARP12 PARP16

查看 Histone Methyltransferase 亚型特异性产品:

查看所有亚型
EZH1 EZH2 DOT1L SMYD2 SMYD3 SUV39H2/KMT1B EHMT2/G9a/KMT1C EHMT1/GLP/KMT1D SETDB1/KMT2G SETD2/KMT3A NSD2/MMSET/WHSC1 SETD7/KMT7 SETD8/KMT5A PRMT1 PRMT3 PRMT4 PRMT5 PRMT6 PRMT7 PRMT8

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

PARP/EZH2-IN-2 (compound 12e) is a dual target PARP1 and EZH2 inhibitor, with IC50 values of 6.89 and 27.34 nM, respectively. PARP/EZH2-IN-2 shows anticancer activity, with no toxicity to normal cells. PARP/EZH2-IN-2 achieves synthetic lethality indirectly by inhibiting EZH2 to increase the sensitivity to PARP1, and induces cell death by regulating excessive autophagy[1].

IC50 & Target

PARP1

6.89 ± 0.7 nM (IC50)

EZH2

27.34 ± 1. nM (IC50)

体外研究
(In Vitro)

PARP/EZH2-IN-2 (compound 12e) 对 MDA-MB-231 细胞 (IC50=2.84 μM) 和 BT-549 细胞 (IC50=0.91 μM) 显示出最佳的细胞毒性，对正常乳腺细胞系没有毒性[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

PARP/EZH2-IN-2 相关抗体:
体内研究
(In Vivo)

PARP/EZH2-IN-2 (compound 12e) (20-50 mg/kg, 腹腔注射) 表现出良好的抗肿瘤活性，优于 Niraparib (HY-10619) + GSK126 (HY-13470)[1]。

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female BALB/c nude mice (5 weeks after birth, MDA-MB-231 cells subcutaneous injection)[1]
Dosage: 20, 50 mg/kg
Administration: Intraperitoneally for 21 consecutive days
Result: Significantly suppressed tumor growth and downregulated the expression of the PARP1/EZH2 protein in tumor tissues at a dose of 50 mg/kg.
分子量

573.64

Formula

C33H31N7O3
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
参考文献

PARP/EZH2-IN-2 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

PARP/EZH2-IN-2PARPHistone Methyltransferasepoly ADP ribose polymeraseTriple-negative breast cancerMDA-MB-231 cellsBT-549 cellsInhibitorinhibitorinhibit

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称：

  

* 需求量：

* 客户姓名：

 

* Email：

* 电话：

 

* 公司或机构名称：

   留言给我们：

Bulk Inquiry

Inquiry Information

产品名称：
PARP/EZH2-IN-2
目录号：
HY-161083
需求量：

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

   产品名称：

  

* Lot #：

* 客户姓名：

 

* Email：

   电话：

 

* 部门：

* 公司或机构名称：

 

   留言给我们：

Request for HNMR Report

We have received your request and will respond to you as soon as possible.

嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z